An observational evaluation of the off-label prescribing and safety of glycopyrronium bromide for symptomatic treatment of severe sialorrhoea (drooling) and/or hyperhidrosis (excessive sweating) (Glycopyrronium Bromide)

15/10/2018
02/07/2024
EU PAS number:
EUPAS26094
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information